PT625204E - Terapeutica da hepatite - Google Patents
Terapeutica da hepatiteInfo
- Publication number
- PT625204E PT625204E PT93904901T PT93904901T PT625204E PT 625204 E PT625204 E PT 625204E PT 93904901 T PT93904901 T PT 93904901T PT 93904901 T PT93904901 T PT 93904901T PT 625204 E PT625204 E PT 625204E
- Authority
- PT
- Portugal
- Prior art keywords
- hepatitis
- infections
- therapeutics
- hepatitis therapeutics
- treating hepatitis
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 208000006454 hepatitis Diseases 0.000 title 1
- 231100000283 hepatitis Toxicity 0.000 title 1
- 208000002672 hepatitis B Diseases 0.000 abstract 2
- 208000005176 Hepatitis C Diseases 0.000 abstract 1
- 101000874347 Streptococcus agalactiae IgA FC receptor Proteins 0.000 abstract 1
- 208000010710 hepatitis C virus infection Diseases 0.000 abstract 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 abstract 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/55—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83041792A | 1992-02-04 | 1992-02-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT625204E true PT625204E (pt) | 2002-10-31 |
Family
ID=25256972
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT93904901T PT625204E (pt) | 1992-02-04 | 1993-02-04 | Terapeutica da hepatite |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0625204B1 (pt) |
JP (3) | JPH07503615A (pt) |
AT (1) | ATE219522T1 (pt) |
AU (2) | AU3610293A (pt) |
CA (1) | CA2128896A1 (pt) |
DE (1) | DE69332045T2 (pt) |
DK (1) | DK0625204T3 (pt) |
ES (1) | ES2174845T3 (pt) |
PT (1) | PT625204E (pt) |
WO (1) | WO1993015207A2 (pt) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6297048B1 (en) | 1992-02-04 | 2001-10-02 | Chiron Corporation | Hepatitis therapeutics |
FR2711670B1 (fr) | 1993-10-22 | 1996-01-12 | Pasteur Institut | Vecteur nucléotidique, composition le contenant et vaccin pour l'immunisation à l'encontre d'une hépatite. |
DK0725824T3 (da) | 1993-11-04 | 2003-08-11 | Innogenetics Nv | Immunodominante humane T-celleepitoper af hepatitis C virus |
AU2585395A (en) | 1994-05-09 | 1995-11-29 | Chiron Corporation | Retroviral vectors having a reduced recombination rate |
US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US20030026782A1 (en) | 1995-02-07 | 2003-02-06 | Arthur M. Krieg | Immunomodulatory oligonucleotides |
US6235888B1 (en) | 1994-10-05 | 2001-05-22 | The General Hospital Corporation | Hepatitis C virus vaccine |
JPH11501204A (ja) * | 1994-10-05 | 1999-02-02 | アポロン・インコーポレーテッド | 肝炎ウィルスワクチン |
US5856169A (en) * | 1995-02-21 | 1999-01-05 | Thomas Jefferson University | Isoforms of human interleukin-1β converting enzyme and methods of using the same |
RU2189254C2 (ru) * | 1995-06-06 | 2002-09-20 | Америкэн Хоум Продактс Корпорэйшн | Вакцины против вирусов гепатита |
DE69738521T2 (de) | 1996-04-05 | 2009-05-07 | Novartis Vaccines and Diagnostics, Inc., Emeryville | Alphaviren-vektors mit einer reduzierten inhibierung der synthese von zellmakromolekülen |
IL139813A0 (en) | 1998-05-22 | 2002-02-10 | Loeb Health Res Inst At The Ot | Methods and products for inducing mucosal immunity |
CN1753687A (zh) | 2002-10-29 | 2006-03-29 | 科勒制药集团股份有限公司 | Cpg寡核苷酸在治疗丙型肝炎病毒感染中的应用 |
JP4474198B2 (ja) * | 2004-05-19 | 2010-06-02 | 株式会社日立ハイテクノロジーズ | C型肝炎ウイルス恒温増幅用プライマー |
US8071561B2 (en) * | 2007-08-16 | 2011-12-06 | Chrontech Pharma Ab | Immunogen platform |
KR20190060879A (ko) * | 2011-03-02 | 2019-06-03 | 제롬 쉔타그 | 단독으로 또는 c형 간염 바이러스 감염과 결합되는 간 지방증의 치료를 위한 조성물, 방법 및 진단 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE132534T1 (de) * | 1986-08-01 | 1996-01-15 | Commw Scient Ind Res Org | Rekombinanter impfstoff |
WO1988006185A1 (en) * | 1987-02-11 | 1988-08-25 | Scripps Clinic And Research Foundation | Retroviral expression vectors and methods for producing hbv antigens |
WO1991015596A1 (en) * | 1990-04-04 | 1991-10-17 | Protos, Inc. | Hepatitis c virus protease inhibitors |
PL172133B1 (pl) * | 1990-04-04 | 1997-08-29 | Chiron Corp | Sposób tworzenia kombinacji antygenów wirusowego zapalenia watroby typu C (HCV) i sposób wykrywania przeciwcial przeciw wirusowemu zapaleniu watroby typu C (HCV) PL PL PL PL PL PL |
FI913068A (fi) * | 1990-06-25 | 1991-12-26 | Univ Osaka Res Found | Non-a-, non-b-hepatitisviruspartiklar. |
CA2049679C (en) * | 1990-08-24 | 2005-06-21 | Sushil G. Devare | Hepatitis c assay utilizing recombinant antigens |
-
1993
- 1993-02-04 DE DE69332045T patent/DE69332045T2/de not_active Expired - Fee Related
- 1993-02-04 AU AU36102/93A patent/AU3610293A/en not_active Abandoned
- 1993-02-04 JP JP5513523A patent/JPH07503615A/ja active Pending
- 1993-02-04 AT AT93904901T patent/ATE219522T1/de not_active IP Right Cessation
- 1993-02-04 DK DK93904901T patent/DK0625204T3/da active
- 1993-02-04 CA CA002128896A patent/CA2128896A1/en not_active Abandoned
- 1993-02-04 ES ES93904901T patent/ES2174845T3/es not_active Expired - Lifetime
- 1993-02-04 EP EP93904901A patent/EP0625204B1/en not_active Expired - Lifetime
- 1993-02-04 WO PCT/US1993/001009 patent/WO1993015207A2/en active IP Right Grant
- 1993-02-04 PT PT93904901T patent/PT625204E/pt unknown
-
1996
- 1996-12-12 AU AU75309/96A patent/AU7530996A/en not_active Abandoned
-
1999
- 1999-11-24 JP JP11333523A patent/JP2000154152A/ja active Pending
-
2002
- 2002-08-06 JP JP2002229247A patent/JP2003055265A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DK0625204T3 (da) | 2002-07-15 |
ATE219522T1 (de) | 2002-07-15 |
WO1993015207A2 (en) | 1993-08-05 |
AU3610293A (en) | 1993-09-01 |
EP0625204B1 (en) | 2002-06-19 |
WO1993015207A3 (en) | 1994-01-06 |
JP2000154152A (ja) | 2000-06-06 |
CA2128896A1 (en) | 1993-08-05 |
JP2003055265A (ja) | 2003-02-26 |
DE69332045T2 (de) | 2002-10-17 |
JPH07503615A (ja) | 1995-04-20 |
EP0625204A1 (en) | 1994-11-23 |
AU7530996A (en) | 1997-02-20 |
DE69332045D1 (de) | 2002-07-25 |
ES2174845T3 (es) | 2002-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT625204E (pt) | Terapeutica da hepatite | |
GB2272443A (en) | Hepatitis C diagnostics and vaccines | |
ATE512224T1 (de) | Rekonstituierter menschlicher anti-hm.1 antikörper | |
NO940660L (no) | HLA - begrensete Hepatit B virus CTL-epitoper | |
HUT75166A (en) | Composition for treating hepatitis c | |
AU1471797A (en) | Hybrid protein between CS from plasmodium and HBsAG | |
ATE402715T1 (de) | Hcv-impfstoff zusammensetzungen | |
DK0588578T3 (da) | Immunogener | |
DE69130071T2 (de) | Zusammensetzung verwendbar als therapeutisches mittel gegen chronische virale leberkrankheiten | |
NO912825D0 (no) | Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper. | |
GR3026519T3 (en) | New method of treating depression | |
EP0687182A4 (en) | PEPTIDES FOR INDUCING A RESPONSE OF THE CYTOTOXIC T-LYMPHOCYTES AGAINST THE HEPATITIS B VIRUS | |
DE69528074D1 (de) | Chitosan induzierte verstärkung | |
DE69332111D1 (de) | Darmprotozoen-Impfstoffe | |
ES2159287T3 (es) | Peptidos hemorreguladores. | |
NL300336I2 (nl) | Vaccin tegen de bof dat een jeryl-lynn virusstam bevat | |
PH31116A (en) | Methods for the treatment of infection caused by hepatitis B virus (hbv). | |
ATE285791T1 (de) | Impfstoff, der acemannan als adjuvans enthält | |
DK0831881T3 (da) | CETP til forøgelse af HDL-cholesterolniveau | |
DK0676965T3 (da) | Fremgangsmåde til at reducere immunogeniciteten af variable regioner på antistoffer | |
DE69130953T2 (de) | Immunverstärkung von impfstoffen, besonders von impfstoffen gegen schweinepleuropneumonie | |
DE59310372D1 (de) | Verfahren zur immunchemischen Quantifizierung von inaktivierten, immunreaktiven Antigenen | |
IT8221787A0 (it) | Procedimento per la preparazione di antigene superficiale puro dell'epatite b da plasma umano. | |
DE69113520T2 (de) | Monoklonale Antikörper gegen HIV GP120. |